Average Co-Inventor Count = 3.75
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cancer Research Technology Limited (17 from 262 patents)
2. Merck Patent Gmbh (2 from 2,938 patents)
3. Children's Medical Center Corporation (2 from 1,036 patents)
4. The Institute of Cancer Research: Royal Cancer Hospital (51 patents)
19 patents:
1. 11897877 - Inhibitor compounds
2. 11046688 - Inhibitor compounds
3. 10501462 - Pyrrolo[3,2-c]pyridine-6-amino derivatives
4. 10479788 - Compounds that inhibit MPS1 kinase
5. 10399974 - N2-phenyl-pyrido[3,4-D]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors
6. 10188642 - Pharmacologically active compounds
7. 10059664 - Sepiapterin reductase inhibitors for the treatment of pain
8. 9926319 - Pyridyl piperidines
9. 9902721 - N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors
10. 9895364 - Pharmacologically active compounds
11. 9890157 - Inhibitor compounds
12. 9834541 - 2-aminopyridine compounds
13. 9834552 - Inhibitor compounds
14. 9447092 - Pharmaceutically active compounds
15. 9409907 - Inhibitor compounds